LA HB15

Adds two synthetic opioids to Schedule I: N-Desethyl isotonitazene and Etonitazepipne, both benzimidazole-class compounds

Adds Ethylphenidate, a central nervous system stimulant, to Schedule I

Schedule I classification means these substances are considered to have high abuse potential with no accepted medical use in Louisiana

Directs the Louisiana State Law Institute to renumber entries to maintain alphabetical order within the schedules